29/09 2023 Non-regulatory Redsense Medical AB’s shares to begin trading at OTCQX on September 29, 2023 Redsense Medical AB has been qualified and approved to enter share trading on the OTCQX trading platform in the United States. Trading of the share… [read more]
28/09 2023 Non-regulatory Major shareholding notification Redsense Medical AB hereby announces that ShapeQ GmbH has passed the disclosure threshold of 5 percent shareholding. Through recent share purchases, ShapeQ GmbH has acquired… [read more]
27/09 2023 Non-regulatory Redsense Medical arranged Congressional Briefing to address Venous Needle Dislodgement The briefing was held on September 27, 2023 in the Rayburn House Office Building, Washington DC with the purpose to bring together various stakeholders in… [read more]
